AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Positive results reported: Electroporation-enabled DNA delivery sans anesthesia.
2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Genetronics Biomedical Corp.Bernie Hertel, +1-858-410-3101
Genetronics Biomedical Corp. (GEB), a late-stage developer of cancer and other therapies using electroporation-enabled delivery of drugs, DNA vaccines, and genes, announced a study assessing the clinical utility of an electroporation-mediated method for delivering DNA in humans without anesthesia showed this method was safe and tolerable.
The results of this Investigational Review board-approved pilot study, which measured pain response in healthy volunteers using an electrical pulse suitable for DNA delivery using Genetronics' MedPulser DNA Delivery System, support electroporation as a potentially attractive DNA delivery method for use in humans to treat serious or life-threatening diseases.
The results were documented in a paper entitled "Assessment of the Pain Associated with Electroporation in Healthy Volunteers" and presented at the Gordon Research Conference on Bioelectrochemistry in July 2004.
"Genetronics has already shown that electroporation is safe and efficient for ...
- Genetronics and Vical Establish Worldwide License for MedPulser(R) DNA Delivery...
- Press release article from: PR Newswire October 26, 2004 700+ words
...Genetronics' MedPulser(R) DNA Delivery System in conjunction with Vical...value of our MedPulser(R) DNA Delivery System to facilitate the use of DNA...application with the MedPulser(R) DNA Delivery System in solid tumors and evaluating...
- Genetronics and Merck Sign Licensing Agreement for MedPulser DNA Delivery...
- Press release article from: PR Newswire May 25, 2004 700+ words
...Genetronics' MedPulser(R) DNA Delivery System, which will be developed for...acknowledgement of our MedPulser(R) DNA Delivery System and intellectual property...Genetronics' MedPulser(R) DNA Delivery System technology to enhance our work...
- Genetronics and Merck sign licensing agreement for MedPulser(R) DNA delivery...
- Newspaper article from: BIOTECH Patent News May 1, 2004 700+ words
...Genetronics' MedPulser(r) DNA Delivery System, which will be developed for...acknowledgement of our MedPulser(r) DNA Delivery System and intellectual property...Genetronics' MedPulser(r) DNA Delivery System technology to enhance our work...
- Genetronics and Merck Sign Licensing Agreement for MedPulser(R) DNA Delivery...
- Press release article from: PR Newswire May 24, 2004 700+ words
...Genetronics' MedPulser(R) DNA Delivery System, which will be developed for...acknowledgement of our MedPulser(R) DNA Delivery System and intellectual property...Genetronics' MedPulser(R) DNA Delivery System technology to enhance our work...
- Tripep Produces Additional Positive Data for Its Hepatitis C DNA Vaccine Using...
- Press release article from: Business Wire August 28, 2006 700+ words
...Inovio's MedPulser(R) DNA delivery system produced a strong immune response...ChronVac-C with the MedPulser DNA delivery system may work well in humans and...Inovio's MedPulser(R) DNA delivery system," stated Avtar Dhillon...
- Merck Exercises Option for Additional Antigen for Use with Inovio Biomedical's...
- Press release article from: Business Wire May 12, 2005 700+ words
...antigen to be used with Inovio's MedPulser(R) DNA Delivery System, which is being developed for use with certain of...important step in the utilization of our MedPulser(R) DNA Delivery System and intellectual property." About Inovio Biomedical...
- Tripep produces additional positive data for its hepatitis C DNA vaccine using...
- News wire article from: Chemical Business Newsbase August 28, 2006 700+ words
...C DNA vaccine combined with Inovio's MedPulser DNA delivery system produced a strong immune response against hepatitis...assistance of Inovio's electroporation-based DNA delivery system. These muscle cells would be expected to then produce...
- Genetronics and Merck sign licensing agreement for MedPulser DNA delivery...
- News wire article from: Asia Africa Intelligence Wire May 24, 2004 700+ words
...collaboration and licensing agreement with Merck & Co Inc to develop and commercialise Genetronics' MedPulser DNA Delivery System, which will be developed for use with certain of Merck's DNA vaccine programmes. This development and commercialisation...
- Inovio Biomedical Receives Milestone Payment from Merck Regarding MedPulser(R)...
- Press release article from: Business Wire July 13, 2005 700+ words
...the achievement of a clinical milestone by Merck for a plasmid-based vaccine using Inovio's MedPulser(R) DNA Delivery System. The milestone relates to Inovio's license and collaboration agreement with Merck that was initiated in May...
- Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of...
- Press release article from: Business Wire September 14, 2008 700+ words
...vaccines using electroporation-based DNA delivery, announced today that it achieved positive...company's electroporation-based DNA delivery technology. The pre-clinical study...proprietary electroporation-based DNA delivery technology. This experimental therapeutic...
Source: HighBeam Research, Positive results reported: Electroporation-enabled DNA delivery sans...